» Articles » PMID: 24267364

Allergists' Self-reported Adherence to Anaphylaxis Practice Parameters and Perceived Barriers to Care: an American College of Allergy, Asthma, and Immunology Member Survey

Overview
Date 2013 Nov 26
PMID 24267364
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Anaphylaxis is life-threatening and requires rapid medical intervention. Knowledge of treatment guidelines and addressing barriers to care are essential for appropriate management.

Objective: To investigate allergists' self-reported practices in managing patients at risk for anaphylaxis, specifically in following practice parameters for diagnosis, treatment, and appropriate use of epinephrine, and to identify perceived barriers to care.

Methods: Online questionnaires were distributed to members of the American College of Allergy, Asthma, and Immunology. The US physicians who self-identified as "allergist/immunologist" were eligible to participate. The first 500 completed questionnaires were analyzed.

Results: Nearly all (≥95%) reported adherence to practice parameters in prescribing an epinephrine auto-injector and instructing patients on its use, taking a detailed allergy history, counseling patients on avoidance measures, and educating patients on the signs and symptoms of anaphylaxis. More than 90% stated they determined the best diagnostic procedures to identify triggers and coordinated laboratory and allergy testing. Adherence to practice parameters was less robust for providing patients with written action plans and in-office anaphylaxis preparedness. Perceived barriers to care included a significant proportion of patients who were uncomfortable using epinephrine auto-injectors and inadequate knowledge of anaphylaxis among referral physicians.

Conclusion: Allergists overwhelmingly adhere to practice parameter recommendations for the treatment and management of anaphylaxis, including appropriate use of epinephrine as first-line treatment, educating patients, and testing to diagnose anaphylaxis and identify its triggers. Opportunities for improvement include preparing staff and patients for anaphylactic events, providing written action plans, and improving knowledge of referring physicians.

Citing Articles

Biphasic anaphylaxis in a Canadian tertiary care centre: an evaluation of incidence and risk factors from electronic health records and telephone interviews.

Ellis A, Hossenbaccus L, Linton S, Botting H, Badawod E, Burrows A Allergy Asthma Clin Immunol. 2025; 21(1):7.

PMID: 39923108 PMC: 11806842. DOI: 10.1186/s13223-024-00919-2.


A study to assess current approaches of allergists in European countries diagnosing and managing children and adolescents with peanut allergy.

Sharma V, Jobrack J, Cerenzia W, Tilles S, Ryan R, Sih-Meynier R PLoS One. 2020; 15(12):e0241648.

PMID: 33270629 PMC: 7714149. DOI: 10.1371/journal.pone.0241648.


Diagnosis and treatment of anaphylaxis: there is an urgent needs to implement the use of guidelines.

Ribeiro M, Chong Neto H, Filho N Einstein (Sao Paulo). 2017; 15(4):500-506.

PMID: 29236793 PMC: 5875169. DOI: 10.1590/S1679-45082017RW4089.


How far from correct is the use of adrenaline auto-injectors? A survey in Italian patients.

Ridolo E, Montagni M, Bonzano L, Savi E, Peveri S, Costantino M Intern Emerg Med. 2015; 10(8):937-41.

PMID: 25990486 DOI: 10.1007/s11739-015-1255-z.


Anaphylaxis in America: A national physician survey.

Altman A, Camargo Jr C, Simons F, Lieberman P, Sampson H, Schwartz L J Allergy Clin Immunol. 2015; 135(3):830-3.

PMID: 25577592 PMC: 4859205. DOI: 10.1016/j.jaci.2014.10.049.